Inhibikase Therapeutics Inc (IKT) — Free Cash Flow Generation Index
Inhibikase Therapeutics Inc (IKT) has a Free Cash Flow Generation Index of 1.00x as of September 2020. Free cash flow of $75.52K represents 1% of operating cash flow ($75.52K). Check IKT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Inhibikase Therapeutics Inc Free Cash Flow Generation Index (2018–2018)
Historical FCF Generation Index trend for Inhibikase Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Inhibikase Therapeutics Inc cash conversion from operations.
Annual Free Cash Flow Generation for Inhibikase Therapeutics Inc (2018–2018)
Year-by-year Free Cash Flow Generation Index for Inhibikase Therapeutics Inc. Check IKT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2018 | 1.00x | $714.99K | $714.99K | $0.00 | — |